![Robert Cuthbertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Cuthbertson
Directeur/Membre du Conseil chez
ZENYTH THERAPEUTICS LIMITED
Fortune : 5 M $ au 31/05/2026
Profil
Robert Andrew Cuthbertson currently works at CSL Innovation Pty Ltd., as Director, CSL Behring LLC, as Non-independent Executive Director from 2018, Centre for Eye Research Australia, as Director from 2017, Grattan Institute, as Director from 2019, CSL Ltd., as Non-Independent Non-Executive Director from 2018, and the University of Melbourne, as Deputy Chancellor from 2023.
Dr. Cuthbertson also formerly worked at Genentech, Inc., as Senior Scientist from 1992 to 1997, National Institutes of Health, as Member, and Howard Florey Institute, as Member.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CSL LIMITED 0,01% | 17/02/2026 | 71 128 ( 0,01% ) | 5 M $ | 31/05/2026 |
Postes actifs de Robert Cuthbertson
| Sociétés | Poste | Début |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Directeur/Membre du Conseil | - |
| CSL LIMITED | Directeur/Membre du Conseil | 17/10/2018 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Directeur/Membre du Conseil | 01/01/2018 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2016 |
Centre for Eye Research Australia
 Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Directeur/Membre du Conseil | 01/03/2017 |
Grattan Institute
 Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Directeur/Membre du Conseil | 01/01/2019 |
Anciens postes connus de Robert Cuthbertson
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/1997 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Centre for Eye Research Australia
Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Government |
Grattan Institute
Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Commercial Services |
